Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-6,678
Closed -$1.99M – 3608
2025
Q3
$1.99M Buy
6,678
+805
+14% +$263K 0.01% 1155
2025
Q2
$1.86M Buy
5,873
+4,852
+475% +$1.52M 0.01% 954
2025
Q1
$343K Buy
+1,021
New +$371K ﹤0.01% 1703
2024
Q4
– Sell
-3,949
Closed -$1.33M – 2841
2024
Q3
$1.33M Buy
+3,949
New +$1.26M 0.01% 1078
2023
Q4
– Sell
-1,264
Closed -$285K – 2712
2023
Q3
$285K Buy
+1,264
New +$274K ﹤0.01% 1683
2021
Q4
– Sell
-1,367
Closed -$279K – 3632
2021
Q3
$279K Sell
1,367
-2,294
-63% -$452K ﹤0.01% 2459
2021
Q2
$644K Buy
3,661
+1,499
+69% +$264K 0.01% 1544
2021
Q1
$399K Buy
+2,162
New +$347K ﹤0.01% 1951
2020
Q4
– Sell
-3,156
Closed -$345K – 2156
2020
Q3
$345K Buy
+3,156
New +$358K 0.01% 1063

Other funds holding KAI

HRT Financial's KAI Position: Q4 2025 in Review

HRT Financial sold out of Kadant (KAI) in Q4 2025, closing a stake of 6,678 shares — an estimated $1.99M sold.

HRT Financial first reported a position in KAI in Q3 2020 and held it in 9 quarters. The position peaked at $1.99M in Q3 2025. 303 funds tracked by Wall St. Rank hold KAI as of Q4 2025.

  • HRT Financial reported no remaining Kadant position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 6,678 Kadant shares in Q4 2025, an estimated $1.99M.
  • HRT Financial first reported a position in Kadant in Q3 2020 and held it in 9 quarters.
  • HRT Financial's Kadant position peaked at $1.99M in Q3 2025.
  • 303 funds tracked by Wall St. Rank held Kadant as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.